C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies

Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
10/2011
10/04/2011	US8030461 Methods for constructing scDb libraries
10/04/2011	US8030460 Compounds and methods for labeling oligonucleotides
10/04/2011	US8030458 Monoclonal antibodies to tacrolimus and immunoassays methods for tacrolimus
10/04/2011	US8030457 Antigen binding proteins to proprotein convertase subtilisin kexin type 9 (PCSK9)
10/04/2011	US8030456 Nogo receptor antagonists
10/04/2011	US8030455 Pancreatic cancer genes
10/04/2011	US8030454 Anti-hedgehog antibodies
10/04/2011	US8030453 Methods of making an antibody that binds a chemerin polypeptide
10/04/2011	US8030450 Canine RANKL and methods for preparing and using the same
10/04/2011	US8030280 Melanoma antigens and their use in diagnostic and therapeutic methods
10/04/2011	US8030279 Tamandarin analogs and fragments thereof and methods of making and using
10/04/2011	US8030277 Polypeptide and gene encoding the same
10/04/2011	US8030275 Methods for treating obesity using fibroblast growth factor-like polypeptides
10/04/2011	US8030069 Conductive polymer matrix and device for use in the efficient isolation of preferential stem cells; permits the monitoring of cell binding to the solid matrix during the selection process, it is possible to obtain feedback information on the number of selected cells at any time
10/04/2011	US8030067 Whitefly ecdysone receptor nucleic acids, polypeptides, and uses thereof
10/04/2011	US8030027 Method for enhancing recombinant antibody production
10/04/2011	US8030023 Nucleic acid encoding DR5 antibodies and uses thereof
10/04/2011	US8029984 Materials and methods for colorectal cancer screening, diagnosis and therapy
10/04/2011	US8029807 Outer membrane vesicles and uses thereof
10/04/2011	US8029796 Therapeutic anti-cytomegalovirus compounds
10/04/2011	US8029793 Anticancer agents; rheumatic diseases; osteoporosis; antiinflammatory agents; cloning genes
10/04/2011	US8029792 TCR-independent activation of T cells
10/04/2011	US8029790 Monoclonal thyroid stimulating or blocking antibodies, peptide sequences corresponding to their variable regions, and their uses in diagnostic, preventive and therapeutic medicine
10/04/2011	US8029789 Method for the mass production of immunoglobulin constant region
10/04/2011	US8029788 Variants of humanized anti-carcinoma MAb CC49
10/04/2011	US8029787 Method of diagnosing, monitoring, staging, imaging and treating various cancers
10/04/2011	US8029786 Antibodies against a peptide epitope of apolipoprotein B
10/04/2011	US8029783 DR5 antibodies and articles of manufacture containing same
10/04/2011	US8029778 Methods of using TICAM-1, an adapter protein that binds toll-like receptor 3
10/04/2011	CA2431199C Immunotherapeutic kit for the treatment of tumors
10/04/2011	CA2381123C Actinium-225 complexes and conjugates for radioimmunotherapy
10/04/2011	CA2339850C A non-cytolytic recombinant hiv-1 vaccine
10/04/2011	CA2338886C Expression and characterization of hiv-1 envelope protein associated with a broadly reactive neutralizing antibody response
10/04/2011	CA2262819C Monoclonal antibody which agglutinates e. coli having the cs4-cfa/i family protein
10/04/2011	CA2245702C Human cancer antigen of tyrosinase-related protein 1 and 2 and genes encoding same
09/2011
09/29/2011	WO2011120013A2 Vista regulatory t cell mediator protein, vista binding agents and use thereof
09/29/2011	WO2011119979A2 Antibodies to muc16 and methods of use thereof
09/29/2011	WO2011119948A1 Anti-kit antibodies and uses thereof
09/29/2011	WO2011119906A1 HUMAN POLYOMAVIRUS 6 (HPyV6) AND HUMAN POLYOMAVIRUS 7 (HPyV7)
09/29/2011	WO2011119888A2 N-cadherin: target for cancer diagnosis and therapy
09/29/2011	WO2011119661A1 Anti-lrp6 antibodies
09/29/2011	WO2011119524A1 Novel targets for regulation of angiogenesis
09/29/2011	WO2011118804A1 Novel anti-cd98 antibody and use thereof
09/29/2011	WO2011118779A1 Pharmaceutical composition for treatment and prevention of herpesvirus infections
09/29/2011	WO2011118739A1 Novel antibody having modification site introduced therein, and antibody fragment
09/29/2011	WO2011117886A1 Bispecific monoclonal antibody capable of cross reacting with lethal factor (lf) and edema factor (ef), and neutralizing edema toxin (et) as well as lethal toxin (lt) of bacillus anthracis
09/29/2011	WO2011117848A1 Full-length immunoglobulins of the igg isotvpe capable of recognizing a heterosubtvpe neutralizing epitope on the hemagglutinin stem region and their use as anti-influenza medicament
09/29/2011	WO2011117653A1 Disulfide stabilized dvd-lg molecules
09/29/2011	WO2011117648A2 Disulfide stabilised antibodies and fragments thereof
09/29/2011	WO2011117582A1 Dendritic cell inhibitory proteins from ticks
09/29/2011	WO2011117423A1 Immunoglobulin single variable domains directed against cxcr7
09/29/2011	WO2011117330A1 Bispecific antibodies
09/29/2011	WO2011117329A1 Bispecific, bivalent anti-vegf/anti-ang-2 antibodies
09/29/2011	WO2011116954A2 Prophylaxis of colorectal and gastrointestinal cancer
09/29/2011	WO2011116885A1 Monoclonal antibodies for treatment of cancer
09/29/2011	WO2011116527A1 Anti human rankl monoclonal antibodies and uses thereof
09/29/2011	WO2011094259A3 Cd127 binding proteins
09/29/2011	WO2011088215A3 Notch1 binding agents and methods of use thereof
09/29/2011	WO2011079902A3 Biological inhibitors of ror1 capable of inducing cell death
09/29/2011	WO2011059189A3 Method for identifying mesenchymal stem cells by using an anti-tm4sf1 antibody and composition thereof
09/29/2011	WO2011055968A3 Kit for detecting bacterial infection comprising novel monoclonal antibodies
09/29/2011	WO2011050001A3 Anti -botulinum neurotoxin a single domain antibody antibodies
09/29/2011	WO2011044570A3 Recombinant antibodies against h1n1 influenza
09/29/2011	WO2011022725A9 Mimotopes of hiv and uses thereof
09/29/2011	WO2010151632A8 Protein purification by caprylic acid (octanoic acid ) precipitation
09/29/2011	US20110239317 Polynucleotides encoding promyostatin polypeptides
09/29/2011	US20110239316 ANTI-cMET ANTIBODY
09/29/2011	US20110239311 Agonists of NR2F6 For Immunosupression
09/29/2011	US20110237780 Anti-inflammatory dab
09/29/2011	US20110237779 Cdr-repaired antibodies
09/29/2011	US20110237657 Transport-Mediating Colloidal Pharmaceutical Compounds
09/29/2011	US20110237514 PHARMACEUTICAL COMPOSITION FOR TREATING BONE DISEASES WHICH COMPRISES PROTEIN COMPRISING Frizzled1, Frizzled2 OR Frizzled7 EXTRACELLULAR CYSTEINE-RICH DOMAIN
09/29/2011	US20110237454 Marker for diagnosis of exposure to electromagnetic radiation and diagnostic kit comprising the same
09/29/2011	US20110237453 Marker for diagnosis of exposure to electromagnetic radiation and diagnostic kit comprising the same
09/29/2011	US20110237452 Marker for diagnosis of exposure to electromagnetic radiation and diagnostic kit comprising the same
09/29/2011	US20110236975 Growth factor which acts through erb b-4 rtk
09/29/2011	US20110236973 Centrosome proteins and uses thereof
09/29/2011	US20110236969 Methods of generating variant proteins with increased host string content and compositions thereof
09/29/2011	US20110236968 Humanized antibodies against monocyte chemotactic proteins
09/29/2011	US20110236957 Nanoparticle Labeling Reagents and Methods of Use
09/29/2011	US20110236910 Prostate cancer biomarker
09/29/2011	US20110236886 Pathogenicity determinants which can be used as targets for developing means for preventing and controlling bacterial infections and/or systemic dissemination
09/29/2011	US20110236679 Immobilization substrate and method for producing the same
09/29/2011	US20110236455 Novel Regulators of the Innate Immune System
09/29/2011	US20110236427 Antagonists of NR2F6 For Augmenting The Immune Response
09/29/2011	US20110236410 Klebsiella antigens
09/29/2011	US20110236407 Vaccine for runting-stunting syndrome
09/29/2011	US20110236399 Compositions and methods for prophylactic and therapeutic treatment of infection
09/29/2011	US20110236397 Limited proteolysis of cd2ap and progression of renal disease
09/29/2011	US20110236396 Methods and compositions for diagnosing and treating a colorectal adenocarcinoma
09/29/2011	US20110236395 Treatment of fibrotic eye disorders using an mmp2 inhibitor
09/29/2011	US20110236393 Monoclonal antibody production in b cells and uses therof
09/29/2011	US20110236390 IL-17A Antagonists
09/29/2011	US20110236389 Human Angiostatin Interacting and Tumor Metastasis Involving Protein Variants and Uses Thereof
09/29/2011	US20110236388 Bispecific, bivalent anti-vegf/anti-ang-2 antibodies
09/29/2011	US20110236383 Protein Formulation
09/29/2011	US20110236382 Immunosuppressive combination and its use in the treatment or prophylaxis of insulin-producing cell graft rejection
09/29/2011	US20110236380 Ligands that bind il-13
09/29/2011	US20110236378 Non-human mammals for the production of chimeric antibodies
09/29/2011	US20110236375 Antibody variants with enhanced complement activity

1 ... 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 259 260 261 262 263 264 ... 1494